1. Home
  2. GOSS vs WEST Comparison

GOSS vs WEST Comparison

Compare GOSS & WEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • WEST
  • Stock Information
  • Founded
  • GOSS 2015
  • WEST 2009
  • Country
  • GOSS United States
  • WEST United States
  • Employees
  • GOSS N/A
  • WEST N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • WEST Beverages (Production/Distribution)
  • Sector
  • GOSS Health Care
  • WEST Consumer Staples
  • Exchange
  • GOSS Nasdaq
  • WEST Nasdaq
  • Market Cap
  • GOSS 501.2M
  • WEST 421.5M
  • IPO Year
  • GOSS 2019
  • WEST N/A
  • Fundamental
  • Price
  • GOSS $2.37
  • WEST $4.26
  • Analyst Decision
  • GOSS Strong Buy
  • WEST Strong Buy
  • Analyst Count
  • GOSS 6
  • WEST 3
  • Target Price
  • GOSS $8.60
  • WEST $10.00
  • AVG Volume (30 Days)
  • GOSS 3.0M
  • WEST 355.9K
  • Earning Date
  • GOSS 11-05-2025
  • WEST 11-06-2025
  • Dividend Yield
  • GOSS N/A
  • WEST N/A
  • EPS Growth
  • GOSS N/A
  • WEST N/A
  • EPS
  • GOSS N/A
  • WEST N/A
  • Revenue
  • GOSS $40,237,000.00
  • WEST $944,492,000.00
  • Revenue This Year
  • GOSS N/A
  • WEST $28.24
  • Revenue Next Year
  • GOSS $16.11
  • WEST $18.97
  • P/E Ratio
  • GOSS N/A
  • WEST N/A
  • Revenue Growth
  • GOSS N/A
  • WEST 13.05
  • 52 Week Low
  • GOSS $0.66
  • WEST $4.12
  • 52 Week High
  • GOSS $3.60
  • WEST $8.29
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 48.07
  • WEST 35.09
  • Support Level
  • GOSS $2.28
  • WEST $4.24
  • Resistance Level
  • GOSS $2.52
  • WEST $4.54
  • Average True Range (ATR)
  • GOSS 0.15
  • WEST 0.27
  • MACD
  • GOSS 0.02
  • WEST -0.06
  • Stochastic Oscillator
  • GOSS 62.79
  • WEST 11.91

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

Share on Social Networks: